This analysis showed equal frequencies of CSF CD4+CD20+ T cells in symptomatic controls and patients with early MS, and likewise of CSF CD8+CD20+ T cells in the two groups (Figure 2D). The gene discussed is CD4; the disease is myeloid sarcoma.